Bufei Huoxue Capsule Attenuates PM2.5-Induced Pulmonary Inflammation in Mice
Atmospheric fine particulate matter 2.5 (PM 2.5) may carry many toxic substances on its surface and this may pose a public health threat. Epidemiological research indicates that cumulative ambient PM2.5 is correlated to morbidity and mortality due to pulmonary and cardiovascular diseases and cancer....
Main Authors: | Yue Jing, Hongchun Zhang, Zhe Cai, Yukun Zhao, Ye Wu, Xuan Zheng, Ying Liu, Yuying Qin, Mingjie Gu, Jin Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2017/1575793 |
Similar Items
-
Bufei huoxue capsules in the management of convalescent COVID-19 infection: study protocol for a multicenter, double-blind, and randomized controlled trial
by: Yuqin Chen, et al.
Published: (2021-08-01) -
Bufei Decoction Alleviated Bleomycin-Induced Idiopathic Pulmonary Fibrosis in Mice by Anti-Inflammation
by: Shanjun Yang, et al.
Published: (2020-01-01) -
Effect of Bufei Huaxian Decoction combined with prednisone on idiopathic pulmonary fibrosis
by: Dan Jia
Published: (2019-12-01) -
Role of NF- κ B signaling pathway in airway inflammation of rats induced by atmospheric PM25
by: Ru-xuan Zhang, et al.
Published: (2018-01-01) -
Effects and Mechanism of Bufei Yishen Formula in a Rat Chronic Obstructive Pulmonary Disease Model
by: Jiansheng Li, et al.
Published: (2014-01-01)